Two Sigma Investments, LP Maxcyte, Inc. Transaction History
Two Sigma Investments, LP
- $40.3 Billion
- Q1 2024
A detailed history of Two Sigma Investments, LP transactions in Maxcyte, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 86,350 shares of MXCT stock, worth $324,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86,350
Previous 152,360
43.33%
Holding current value
$324,676
Previous $716,000
49.58%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MXCT
# of Institutions
126Shares Held
62MCall Options Held
2.4KPut Options Held
2.1K-
Black Rock Inc. New York, NY7.23MShares$27.2 Million0.0% of portfolio
-
Cadian Capital Management, LP New York, NY6.56MShares$24.7 Million0.98% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.17MShares$23.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$20.1 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$19 Million6.7% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $382M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...